Literature DB >> 17459667

An in vitro study of the elimination of oseltamivir carboxylate by haemofiltration.

Pascale C Gruber, Qi Tian, Charles D Gomersall, Gavin M Joynt, Gordon Y S Choi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17459667     DOI： 10.1016/j.ijantimicag.2007.02.013

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  5 in total

Review 1.  Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.

Authors:  Nicolas Widmer; Pascal Meylan; Anton Ivanyuk; Manel Aouri; Laurent A Decosterd; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2010-11       Impact factor: 6.447

2.  Supratherapeutic oseltamivir levels during continuous dialysis: an expected risk.

Authors:  Gregory A Eschenauer; Simon W Lam
Journal:  Intensive Care Med       Date:  2010-11-20       Impact factor: 17.440

3.  Effect of preexposure to aminoglycosides on in vitro adsorption of amikacin by polyacrylonitrile hemofilters.

Authors:  Q Tian; C D Gomersall; M Ip; G M Joynt
Journal:  Antimicrob Agents Chemother       Date:  2011-04-18       Impact factor: 5.191

4.  Pharmacokinetics of Oral and Intravenous Oseltamivir Treatment of Severe Influenza B Virus Infection Requiring Organ Replacement Therapy.

Authors:  Katharina Karsch; Xi Chen; Oliver Miera; Björn Peters; Patrick Obermeier; Roland C Francis; Válerie Amann; Susanne Duwe; Pieter Fraaij; Alla Heider; Marcel de Zwart; Felix Berger; Albert Osterhaus; Brunhilde Schweiger; Barbara Rath
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-02       Impact factor: 2.441

5.  Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza.

Authors:  Walter R J Taylor; Bui Nghia Thinh; Giang Thuc Anh; Peter Horby; Heiman Wertheim; Niklas Lindegardh; Menno D de Jong; Kasia Stepniewska; Tran Thuy Hanh; Nguyen Duc Hien; Ngo Minh Bien; Ngo Quy Chau; Annette Fox; Nghiem My Ngoc; Martin Crusat; Jeremy J Farrar; Nicholas J White; Nguyen Hong Ha; Trinh Thi Lien; Nguyen Vu Trung; Nicholas Day; Nguyen Gia Binh
Journal:  PLoS One       Date:  2008-10-15       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.